UT San Antonio
UT Health San Antonio
Category ID
171

UT Health San Antonio recognized among nation’s top 100 oncology programs

Honor highlights excellence in cancer care, research and innovation UT Health San Antonio’s Mays Cancer Center has been named among the nation’s leading hospitals and health systems for excellence in oncology programs, according to Becker’s Hospital Review. The publication’s annual list features more than 100 organizations recognized for their contributions in cancer research, innovation and treatment. This marks […]

Share This Story

Advancing awareness of lobular breast cancer

UT Health San Antonio’s Mays Cancer Center is hosting a Grand Rounds Oct. 15 — Global Lobular Breast Cancer Awareness Day — to spotlight new approaches to diagnosis and treatment of invasive lobular carcinoma, a common but often overlooked form of breast cancer.

Share This Story

Wasmuth named Howard Hughes Medical Institute Freeman Hrabowski Scholar

Elizabeth Wasmuth, PhD, assistant professor in the Department of Biochemistry and Structural Biology of the Joe R. and Teresa Lozano Long School of Medicine and co-director of the cryo-EM facility at The University of Texas at San Antonio, has been selected by the Howard Hughes Medical Institute (HHMI) as a Freeman Hrabowski Scholar. The five-year […]

Share This Story

Leading cancer research centers reinforce importance of safe and effective human papillomavirus (HPV) vaccination to prevent cancer

Contact: Eileen Teves, 210-450-7239 Mays Cancer Center joins leading NCI-Designated Cancer Centers in a unified statement to raise awareness about vaccine SAN ANTONIO, Sept. 16, 2025 — Today, the Mays Cancer Center at The University of Texas San Antonio Health Science Center, along with 61 National Cancer Institute (NCI)-Designated Cancer Centers with leading national organizations […]

Share This Story

UT Health San Antonio scientists uncover how some cancers outsmart immune system

FOXM1 protein identified as key driver in immunotherapy resistance, unlocking new therapeutic avenues   For years, scientists have found the overexpression of a specific protein called FOXM1 in a wide range of cancers, including ovarian, breast and pediatric cancers. A recent study by scientists at The University of Texas Health Science Center at San Antonio […]

Share This Story

Dr. Kurmasheva awarded CURE foundation grant for childhood cancer research

A cancer diagnosis is always devastating and is especially overwhelming when the patient is a child. This is why the CURE Childhood Cancer Foundation is on a mission to advance research that will bring an end to childhood cancers. Recently, Raushan Kurmasheva, PhD, assistant professor at the Greehey Children’s Cancer Research Institute and Department of […]

Share This Story

Owens Medical Research Foundation awards UT Health San Antonio investigators $1.5 million to advance Alzheimer’s and cancer research

  The William and Ella Owens Medical Research Foundation recently awarded $1.5 million to The University of Texas Health Science Center at San Antonio (UT Health San Antonio) for research projects that address pancreatic cancer, Alzheimer’s disease and childhood cancers. This year, the foundation will fund $250,000 each to six research projects from UT Health […]

Share This Story

Max and Minnie Tomerlin Voelcker Fund grants UT Health San Antonio $1.25 million to support research from early career investigators

  The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded $1.25 million by the Max and Minnie Tomerlin Voelcker Fund to support research projects being conducted by the institution’s early career investigators. Voelcker Fund Young Investigator Awards The Voelcker Fund Young Investigator Award will fund each recipient’s […]

Share This Story

Key DNA complex connected to PARP inhibitor cancer-drug resistance discovered

Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have made one of the most important discoveries to date in the study and treatment of BRCA1-deficient cancers and drug resistance. Approximately one in 300 Americans have a pathogenic mutation in the BRCA1 or BRCA2 gene, placing them at an […]

Share This Story

CPRIT awards UT Health San Antonio $3.4 million to increase HPV vaccination rates in Bexar County, develop transformative technologies targeting drug-resistant cancers

  The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received $3,395,970 in new academic research and prevention awards as part of the latest $98 million funding round announced on May 21 by the Cancer Research Prevention Institute of Texas (CPRIT). The state agency, which focuses on funding evidence-based cancer […]

Share This Story

Subscribe to Cancer